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Abstract
Victoria Giordano
THE EFFECT OF QUALITY OF LIFE AND
HEALTH BEHAVIORS IN SCHIZOTYPY
2014/15
Thomas Dinzeo, Ph.D.
Master of Arts in Clinical Mental Health Counseling
Individuals diagnosed with schizophrenia are typically found to engage in higher
rates of poorer health behaviors, such as higher rates of smoking and poorer nutrition
Along with poorer health behaviors, individuals with schizophrenia tend to report a lower
quality of life than an individual without a schizophrenia diagnosis. Our study chose to
look at schizotypy, or sub-clinical schizophrenia, and it’s relation to quality of life and
health behaviors. We found that individuals that measure high on the subclinical
schizotypy scale tend to mirror the health and quality of life ratings of an individual
diagnosed with schizophrenia – they are more likely to engage in poorer health behaviors
(including higher rates of smoking) and to report a decreased quality of life than
individuals who scored low on the schizotypy scale.
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Chapter 1
Introduction and Literature Review
Schizophrenia is a mental illness categorized in the DSM-TR-IV as a psychotic
disorder characterized by reality distortion (e.g., hallucinations and delusions),
disorganized thoughts and behaviors, and difficulty initiating adaptive behaviors (APA,
2000). While only .05% to 1.5% of the general population will go on to develop
schizophrenia, as many as 10% of the population may experience sub-clinical
manifestations that are believed to be related to schizophrenia (Meehl, 1990). The term
schizotypy refers to the presence of the “sub-clinical” phenomenon and are often used to
diagnose a personality disorder within the DSM-TR-IV Cluster A personality disorders.
Cluster A personality disorders, which include Paranoid Personality Disorder, Schizoid
Personality Disorder, and Schizotypal personality disorder, are characterized by
symptoms such as suspiciousness of others, restricted range of expression, and social and
interpersonal deficits. While the traditional medical model typically takes a categorical
approach to mental illness, many professionals now believe that psychosis may actually
be a continuous spectrum of symptoms/disorder (referred to as schizotypy) ranging from
mild to severe. In this dimensional view of psychopathology researchers anticipate that
the presence of “sub-clinical” schizotypy symptoms is distributed on a continuum in the
population and that the presence of these symptoms also reflects an underlying risk for
the development of the syndrome (e.g., schizophrenia). There is accumulating evidence
that this may be a more valid way of conceptualizing psychosis (Johns & van Os, 2001;
Rossler, Riecher-Rossler, Angst, et al., 2007).
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Both schizophrenia and schizotypy are suggested to have three basic symptom
clusters: positive symptoms, negative symptoms and disorganized symptoms (Vollema &
Hoijtink, 2000; Vollema & van der Bosch, 1995). Positive symptoms in schizophrenia
are defined as an excess or distortion of normal behavior or cognition (e.g., hallucinations
and delusions). These can be manifested in several different ways, with auditory
hallucinations being the most common type of hallucination reported (Rollins et al.
2010). In those with schizotypy, positive symptoms manifest themselves more subtly. For
example, seeing something out of the corner of your eye that is not really there or hearing
somebody call your name in an empty room. Negative symptoms in schizophrenia are
defined as a static phenomenon characterized by the absence of emotive capabilities such
as blunted affect, emotional withdraw, and lack of spontaneity and flow of conversation
(Kay, Fiszbein, and Opler, 1987). The presence of these negative symptoms in
individuals with schizophrenia is often associated with a poorer outcome in both Quality
of Life (QOL) and overall social functioning (Hoffman, Kupper, and Kunz, 2000). In
schizotypy, negative symptoms of schizophrenia may manifest themselves as having the
inability to develop and maintain social relationships or struggling to connect with
another person. Disorganized symptoms tend to present themselves in clinical symptoms
such as a formal thought disorder and “bizarre” behavior and express themselves
independently of the positive and negative schizophrenia symptoms (Bergman et all,
1996; BIlder et al., 1985). In schizotypy, disorganized symptoms may manifest as
eccentric behavior or odd speech. For example, an individual experiencing disorganized
symptoms may be hard to follow while speaking or may jump from one subject to the
next.
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When the symptoms of schizophrenia are identified and treated early, the research
literature suggests that the long-term prognosis may be considerably better than if
symptoms are allowed to persist. A meta-analysis of literature on duration of untreated
psychosis has shown a negative correlation between the onset of psychosis (mostly
negative symptoms) and receiving treatment and that intensive education campaigns
raising awareness is an important and necessary part of early detection (Perkins et al.,
2005; Foley et al., 2007; Joa et al., 2007). Early detection and intervention may help
prevent “social, interpersonal, cognitive, and affective disruptions that accompany and
follow a psychotic episode” (Tsuag, Stone, & Faraone, 2000). Examining levels of
schizotypy may be one of the best predictors of developing schizophrenia; one study
found that about 11% of individuals who endorsed schizotypal symptoms were diagnosed
with schizophrenia within 39 months (Miller et al., 2002). While the causality of specific
factors in why certain “high risk” individuals develop schizophrenia while some do not
continues to be unclear, evidence has shown that the development and exacerbation of
symptoms may be linked to environmental factors such as physical health. For example,
one study found that the increased frequency of physical diseases such as cardiovascular
disease and diabetes may be partly accounted for by the development of schizophrenia
and its treatment (Leucht et al., 2007).
Problematic Lifestyle Behaviors in Schizophrenia and the Spectrum Disorders
People with schizophrenia tend to have greater health problems and unhealthier
lifestyles when compared to the general population (Samele et al., 2007). These issues
appear to contribute to the early mortality (Brown, 1997). On average, people with
schizophrenia survive only 36.2 years after receiving their diagnosis of schizophrenia
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(Capasso et al., 2008). While suicide and accidental deaths contribute to these high
mortality rates for people with schizophrenia, there is also evidence that early mortality is
also associated with poor health practices (Brown, Barraclough, & Inskip, 2000). In
general, individuals with serious mental illnesses have been found to give less priority to
their physical health when compared to a control group, with diagnosed individuals
attributing control over their physical health to external factors such as powerful others
and chance (Buhagiar et al., 2011).
One of the most problematic health behaviors for individuals with schizophrenia
is nicotine use. It has been estimated that somewhere between 75% and 90% of
individuals diagnosed with schizophrenia smoke compared to the 30% to 40% of smokers
in the general population (Davis et al., 2002; Samele et al., 2007). Though the CDC
warns that excess cigarette and tobacco use can cause cancer, heart disease, stroke, and
lung diseases (including emphysema, bronchitis, and chronic airway obstruction),
individuals diagnosed with schizophrenia are more likely to smoke cigarettes, are more
likely to smoke cigarettes in excess, and have overall higher nicotine use than in the
general population (Center for Disease Control and Prevention,2008; Campo-Arias et al.,
2006; Kilian et al., 2006). The surprisingly-high rates of nicotine use in people with
schizophrenia may be related to the temporary relief of negative symptoms associated
with smoking. These symptoms may be a lack of motivation and interest or may be a
short lived increase in memory, learning, attention, and thinking speed (Kumari &
Postma, 2005). One post-mortem study found that mortality in smoking schizophrenia
patients was related to tobacco related illnesses such as heart disease (29%), cancer
(19%), and pulmonary disease (17%) (Goff et al., 2005). While much of the research
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focuses on nicotine use in schizophrenia, some studies have also shown elevated nicotine
use in individuals with schizotypy. Allan et al., 1995 have found a positive correlation
between self-reported schizotypy and number of cigarettes smoked per day. Similarly,
individuals with elevated nicotine use also tend to endorse higher levels of schizotypy
(particularly disorganized symptoms); however, this was only found to be significant in
individuals that had family members diagnosed with schizophrenia (Esterberg et al.,
2007; 2009).
In addition, lack of exercise and poor nutritional health also continue to be a
contributing factor to the health problems. Individuals with schizophrenia are more likely
to have an elevated risk for cardiovascular disease and an increasingly elevated risk of
obesity, diabetes, and hypertriglyceridemia (Goff et al., 2005). When compared to the
general population, individuals with schizophrenia are also more likely to consume
alcohol and caffeine daily, and to have higher daily consumption of salt and saturated fat
(Bobes et al, 2010). Individuals diagnosed with schizophrenia also tend to have a higher
BMI (body mass index), higher rates of unhealthy eating habits, higher likelihood to be
diagnosed with type II diabetes, and reported engaging in less physical activity than the
general population (Kilian et al., 2006; Lambert, Velakoulis, & Pantelis, 2003; Connoly
& Kelly, 2005). As a result, the likelihood of developing cardiovascular disease is 12
times higher than the general population (Beebe, 2008). It is possible that these health
issues begin prior to the development of psychosis (i.e., in those with schizotypy or who
are in the early stage of illness) and may influence the development of schizophrenia. The
health issues could create an additional “strain” on the individual that influences the
development of early symptomology and could potentially decrease quality of life. The
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experience of stress has been related to increased risk for the development of
schizophrenia. This model, known as the diathesis-stress model, states that when both an
individual’s genetic predisposition and environmental stressors interact, the individual
begins to express symptomology. While genetics may be highly relevant to the etiology
of schizophrenia, not everyone with genetic predisposition will develop schizophrenia
(Fowler, 1992). It is possible that if, with early recognition of genetic predispositions of
schizophrenia, health care providers could target lifestyle/health issues and quality of life
to decrease the likelihood of the expression of schizophrenia symptoms.
Issues related to “Quality of Life” in Schizophrenia and Spectrum Disorders
In the field of psychology, the term Quality of Life (QOL) is a multi-dimensional
construct that involves an individual’s subjective rating of happiness, life satisfaction,
and subjective well-being. Researchers view ratings of QOL as an indicator for mental
health and adjustment. The ratings of QOL allow researchers to obtain a more complete
view of mental and physical health status beyond mere “symptom severity” while
providing information that can inform the development of new treatments (Frisch, 1994).
Negative symptoms appear to be associated with the poorest QOL ratings overall.
Individuals with prominent negative symptoms appear to be “less equipped to deal with
the demands of their environment and, consequently, experience impoverished QOL”
(Cohen & Davis, 2009). Typically, individuals who have more severe negative symptoms
also have lower ratings of QOL, particularly in domains of social activity. Although
further research is needed, it has been suggested that individuals with schizophrenia may
feel hopeless about addressing issues that affect their QOL (Cohen & Davis, 2009).
Likewise, individuals diagnosed with schizotypal personality disorder also tend to report
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a lower level of subjective well-being. These ratings tend to be even lower than most
other personality disorders (Cramer, Torgersen, & Kringlen, 2006). While deterioration
of QOL may precede overt symptom formation, QOL does not appear to be determined
by the severity of schizophrenia-spectrum symptoms alone (Melle et al., 2005). Recent
research has shown that health problems are also related to decreased ratings of QOL in
people with schizophrenia-spectrum conditions (Hausswolff-Juhlin et al., 2009). Health
related QOL measures appear to mediate subjective ratings of general QOL, self-esteem,
anxiety, and depression in individuals with schizophrenia (Meijer et al., 2008). Further
research is needed to gain a more comprehensive picture of how co-occurring clinical
symptoms and medical/health issues are related to QOL in this population. This is a
potentially important area of research because health issues (and the reduced QOL
associated with these issues) may be associated with increased risk for the development
of schizophrenia in those with schizotypy. If research can demonstrate that health
problems and poor QOL serve as early risk indicators, then it is possible that early
interventions could be developed that address these issues and increase the likelihood of a
better overall outcome.
The purpose of this study is to focus on two common areas of concern within
psychotic disorders: Health/Lifestyle Behaviors and QOL. Based on the empirical
literature we hypothesized that: (1) Individuals who score higher on schizotypy traits will
endorse a poorer QOL and will have a higher rate of problematic health behaviors
(including increased nicotine use, poorer nutrition, less physical activity, etc.) , and
(2)that poor lifestyle/health behaviors will moderate the relationship between levels of
schizotypy and QOL; Stated another way, individuals that have high levels of schizotypy
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and poor lifestyle behaviors will have significantly poorer QOL than those with healthier
lifestyles. We expect that this relationship will be significant in those with more
prominent negative symptoms.
Instead of focusing on the clinical population of people diagnosed with
schizophrenia we are proposing to examine these issues in college students with varying
levels of schizotypy for a few different reasons: First, there appears to be a lack of
research examining health/lifestyle issues in the schizotypy literature. This is unfortunate
since these issues could influence levels of “risk” for transitioning to psychosis. Second,
the examination of these issues in a “non-clinical” sample has the benefit of bypassing
the confounding effects of anti-psychotic medication use that would be present in a
clinical sample of patients (e.g., weight gain and health issues related to anti-psychotic
medication use). Third, traditional college students are at an age (18-25) where the risk
for the development of a psychotic disorder is the greatest. Thus, we believe that this
form of research can expand our knowledge about the factors that contribute to “risk” for
psychosis and may allow for the development of new interventions that include a focus
on physical health / lifestyle and QOL issues.
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Chapter 2
Method
Participants
Participants in this study were made up of 395 college age participants (M= 20.8)
at a Northeastern University. Inclusionary criteria for this study specified that participants
be eighteen years of age or older. The sample was 63.5% female and was 81.0%
Caucasian. Please refer to Table 1 for additional information.

Table 1
Participant Characteristics
Characteristic
Gender (%)
Male
Female
Age
M
SD
Range
Ethnicity (%)
White/Caucasian
African American
Hispanic
Other

Distribution
36.5
63.5
20.8
3.58
18–48
81.0
8.4
6.6
4.0

Procedures
This study was given IRB approval by the university and all participants
consented to participate in this study. Participants in this study were recruited through

9

two different ways. One hundred and twenty four participants received credit for
participating in the study through an undergraduate Essentials of Psychology course and
were given assessments through paper-and-pencil questionnaires. The other 245
participants were recruited online via Rowan University and entered in a drawing to win
a $40.00 gift certificate. Participants in the online assessment were recruited through
online university newsletter. Students that were interested in completing the survey were
given a link to our online questionnaire.
Measures
Schizotypal personality questionnaire–brief revised (SPQ–BR). The SPQ–BR
(Cohen et al., 2010) was used to measure the construct of schizotypy. This measure is
composed of 32 statements, which include, “Other people see me as slightly eccentric
(odd).” These statements are rated on a Likert-type scale with 1 (Not at all like me) to 5
(Very much like me). This measure has three subscales which include Interpersonal,
Cognitive-Perceptual, and Disorganized. Scores were summed to obtain subscale and
total scores, with higher scores indicating more schizotypy personality characteristics.
Prior research found the SPQ–BR to have high internal consistency (Cronbach’s α=.80.90) .80 and .90 (Cohen, 2010). Please refer to Table 2 for alpha reliabilities for the SPQ–
BR measure from the current sample.
Lifestyle and habits questionnaire-brief (LHQ–B). The LHQ–B (Dinzeo,
Sledjeski, & Thayasivam, 2013) was used to measure lifestyle health habits. This
measure is composed of42 statements, such as “I am physically fit as most people my
age”, and “I eat five or more servings of fruits and vegetables daily” that are rated on a
Likert-type scale with 1 (Strongly Disagree) to 5 (Strongly Agree). There are 8 separate
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Table 2
Alpha Reliabilities Across Measures
Alpha
Reliability

Measure
Schizotypal Personality Questionnaire (BR)
Cognitive Perceptual Distortions
Interpersonal Deficits
Disorganized Thoughts

Α
.85
.87
.88

Quality of Life Inventory
Total Score

Α
.78

Life and Health Behaviors Questionnaire
Health and Exercise
Psychological Health
Substance Use
Nutrition
Environmental Concern
Social Concern
Accident Prevention/Safety
Sense of Purpose

α
.91
.77
.87
.77
.79
.69
.65
.66

lifestyle domains, including physical health & exercise, psychological health, substance
abuse, nutrition, environmental concern, social concern, accident prevention, and sense of
purpose. Internal consistency of this measure range from fair to excellent (.65 to .91) and
overall demonstrates good psychometric properties. Scores can be summed across
domains to indicate of the presence of positive lifestyle habits. Please refer to Table 2 for
alpha reliabilities for the LHQ-B measure from the current sample.
Quality of life inventory (QOLI). The QOLI (Frisch, 1994) is a scale composed
of 32 questions which include, “How important is health to your happiness?” These
statements are rated on two Likert-type scale with one scale with 0 (Not important) to 2
(Extremely important) and the other scale with -3 (Very) to +3 (Very). Domains of the
11

QOL Index include total importance, total satisfaction, health, esteem, goals, money,
work, play and learning with all domains included in the present study. The QOL Index
had an internal consistency of .79 (Frisch, 1994). Scores were summed with higher scores
indicating a more positive QOL rating. Please refer to Table 2 for alpha reliabilities for
the QOLI measure from our current sample.
Nicotine and substance use. We measured alcohol, nicotine, and substance use
through an informal questionnaire asking about the frequency and amount of current use.
For nicotine use, participants were asked about the number of times per day (on average)
that they use nicotine products (cigarettes, chewing tobacco, cigars, etc.). Alcohol use
was determined by asking participants to estimate the rate of alcohol consumption (per
standard unit) per week. Similarly, participants were asked to report the number of times
per week they used marijuana. A separate question also asked about the use of “other
substances” per week.
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Chapter 3
Results
Prior to the data analysis, QOL data, schizotypy data, and health behavior data were
examined for outliers, missing data, and normality. Reported significance levels are two-tailed
unless otherwise noted. Analyses of variance (ANOVA) and Pearson product correlations were
used to identify potential confounding variables that could bias our main analyses such as age,
ethnicity, and gender. Most data met normal assumptions, although we found significant positive
skew for our substance use variables (alcohol, marijuana, and nicotine). Thus, most participants
reported no (or very little) use of these substances. These variables were ultimately dichotomized
and Chi Square analyses were used to examine evidence for our hypotheses involving these
variables (described in greater detail in the Results section). Chi-Square was also used to
determine relationship between gender and alcohol, marijuana, and nicotine use. It was found
that there were only marginally significant relationships between gender and nicotine use
(χ=3.13, p=.07), however, there were significant relationships between gender and alcohol use
(χ=4.19, p=.04) and gender and marijuana use (χ=18.59, p>.001) with females having higher
rates of alcohol use and males having higher rates of marijuana use. Please refer to Tables 3, 4,
and 5 for additional information related to the Chi-Square analyses.
T-Tests were conducted to identify confounding variables. Significant gender differences
were found within the SPQ and QOL total scores. Males scored significantly higher [t(1, 393) =
2.093, p= .037] on the QOL total score than females: M(SD)2.13(1.35) & 1.83(1.38),
respectively. However, females scored significantly higher on the SPQ [t(1,393) = -.2829, p<
.01] than males: M(SD) 86.77(20.09) & 80.81(20.17), respectively. Due to these differences,
gender was added as a covariate in the regression model.
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Table 3
Bivariate Correlations Between Health, Substance, and QOL Domains

1. SPQ Total
2. Health Behaviors (LHQ)
3. Nutrition (LHQ)
4. Nicotine Use*
5. Alcohol Use*
6. Marijuana Use*
7. Quality of Life

SPQ total

Health
behaviors
(LHQ)

Nutrition
(LHQ)

—
0.337**
0.112*
1.82**
0.038
-0.047
0.419**

—
—
0.508**
-0.041
0.041
0.032
0.475**

—
—
—
0.003
0.091
0.074
0.252**

Nicotine use
—
—
—
—
0.136**
0.191
0.097

** indicates significance under .01, * indicates significance under .05
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Table 4
Chi-Square Analyses Between Gender and Dichotomized Substance Use Domains

Nicotine use
Alcohol use
Marijuana use

Pearson chisquare
3.132
4.194
18.593

df
1
1
1

Sig.
.077
.041
.000

Alcohol use

Marijuana
use

Quality of
life (total)

—
—
—
—
—
0.136
0.012

—
—
—
—
—
—
0.043

—
—
—
—
—
—
—

Table 5
Descriptive Statistics for Each Measure Across Levels of Schizotypy and ANOVA Results
Schizotypy groups
Low
Measure
SPQ-BR total score
Health behaviors (LHQ)
Nutrition (LHQ)
Nicotine usea
Alcohol usea
Marijuana usea
QOL raw score
Lifestyle total
15

a

M
66.9
.15
.04
-.11
-.02
-.94
2.52
.30

SD
11.8
1.05
1.02
.58
1.02
.79
1.20
2.74

Med
M
83.5
-.42
-.23
.10
.74
.13
1.61
-.97

SD
20.1
.96
.99
1.16
.97
1.26
1.27
2.66

non-dichotomized variable used (also see Chi Square Analyses for these variables)

High
M
113.5
-.66
.01
.63
-.29
-.16
.80
-.77

ANOVA
SD
9.3
1.22
1.20
1.80
.48
.25
1.51
3.35

Post hoc

F

p

17.51
3.16
7.21
1.97
2.66
36.95
2.66

>.001
.043
.001
.141
.071
<.001
.071

L>M>H
L>M>H
H>M>L
NS
NS
L>M>H
L>H>M

Two-tailed bivariate correlations were used to assess the relationship between
schizotypy symptoms (positive, negative, and disorganized) and indicators of QOL and
healthy lifestyle behaviors. An ANOVA was used to assess between-group differences in
levels of QOL (QOL) and health/lifestyle behaviors in people with schizotypy. Levels of
schizotypy were trichotomized into high, medium, and low categories for these analyses.
High levels of schizotypy were defined as scores above 3.61; medium levels of
schizotypy were defined as scores in the 2.60 - 3.60 range; low levels of schizotypy were
defined as 2.59 and below. These groupings are based on 1.5 standard deviations above
and below the mean. Table 6 provides basic descriptive information (e.g., mean scores &
standard deviations) for each measure used in this project; this information is organized
according to levels of schizotypy (low, medium, high).
In order to test Hypothesis #1, bivariate correlations were conducted to determine
if there were any significant relationships between our schizotypy, lifestyle, and QOL
variables (see Table 6). Higher levels of schizotypy was related to reductions in health
behaviors (r= -.337, p > .001), poorer overall nutrition (r= -.112, p= .026), more
problematic overall lifestyle patterns (r= -.223, p >.001), and lower overall quality of life
(r= -.419, p >.001). Individuals that scored higher on the SPQ were also found to report
significantly greater tobacco use (r= .182, p >.001).
To further test Hypothesis #1 we also conducted a one-way ANOVA to examine
whether or not levels of schizotypy (high, med, low) were related to QOL or problematic
health behaviors. The results suggested that there were statistically significant differences
between high, medium, and low groups and QOL behavior F(2, 392)= 36.95, p > .001,
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Table 6
Chi-Square Analysis of Low, Medium, and High Groups in Relation to Nicotine, Alcohol,
and Marijuana Use

Alcohol use
Nicotine use
Marijuana use

Low
M (SD)
.58 (.50)
-.10 (.30)
.05 (.21)

Med
M (SD)
.65 (.48)
.15 (.35)
.12 (.33)

High
M (SD)
.45 (.51)
.26 (.44)
.06 (.25)

health behaviors F(2, 392)= 17.51, p > .001, nutrition F(2, 392)= 3.16, p= .043, nicotine
use F(2,392)= 7.21, p= .001, and overall lifestyle F(2, 392)= 9.83, p > .001.
Consistent with our predictions, post-hoc tests using the Bonferroni correction
found that there were statistically significant differences between low (M=2.52, SD=
1.20), medium (M=1.61, SD= 1.27), and high (M= .80, SD= 1.5) groups in relation to
QOL behavior with individuals scoring low schizotypy symptoms reporting the highest
level of QOL satisfaction. This suggestions that individuals with higher levels of
schizotypy report lower QOL satisfaction than individuals that score low and medium
levels of schizotypy. Additionally, post-hoc analyses found statistically significant
differences between low (M= .15, SD= 1.05), medium (M= -.42, SD= .96), and high (M=
-.66, SD= 1.22) groups and health behaviors, statistically significant differences between
low (M= .04, SD= 1.02), medium (M= -.23, SD= .99), and high (M= .01, SD= 1.2)
groups and nutrition, statistically significant differences between low (M= -.11, SD= .58),
medium (M= .10, SD= 1.16), and high(M= .63, SD= 1.8) groups and nicotine use, and
statistically significant differences between the low (M= .30, SD= 2.74), medium (M= .97, SD= 2.66), and high (M= -.77, SD= 3.35) groups in relation to total lifestyle
satisfaction.
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In order to examine hypothesis #2 multiple hierarchical linear regression models
were constructed to examine the unique variance associated with our variables of interest.
Within this model, QOL was designated (and related sub-domains) as our DV. Gender
was added in the first step of each model regression model in order to control for
potential gender differences within our regression model. Step 2 in our model was used to
enter the IVs of schizotypy and lifestyle. Levels of schizotypy (β= -.627, p > .001) and
lifestyle behaviors (β= 1.50, p >.001) were found to significantly predict QOL aboveand-beyond the influence of gender. The third step of our model was used to look at the
potential moderating effects of lifestyle and schizotypy on QOL through the creation of
an interaction term (i.e., LHQ x SPQ). However, there was no evidence for moderation
when examining the results of our analyses.
Finally, we created a regression model in order to examine the overall
contribution of all variables to QOL. In this model, all independent variables were
entered in the same step and QOL was designated as the dependent variable. Gender was
controlled for and not significant within the model (β= 0.45, p = 0.28, R²= .480). The
results suggested that scores from the SPQ “interpersonal” domain (β=-.253, p >.001),
lifestyle “health” domain (β= .214, p >.001), and lifestyle “psychological health” domain
(β=.292, p >.001) each significantly contributed to Quality of Life. Specifically,
individuals that measured higher on the SPQ interpersonal factor scored lower in Quality
of Life [t(1,393)= -.517, p >.001] while individuals that measured higher in physical
health [t (1,393)= .471, p >.001] and/or psychological health [t(1,393)= .569, p >.001]
measured higher in Quality of Life. These results suggest that while not all of the factors
of our assessments were significant predictors, there are some that can be identified.
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Chapter 4
Discussion
Prior research suggests that there are significant health issues that affect
individuals diagnosed with schizophrenia contributing to poorer quality of life and early
mortality. However, very little is known about when these issues arise during the course
of schizophrenia or if these issues are also relevant during the prodromal stages of illness
or in individuals considered to be at “high risk” for psychosis. In order to address this
questions, the current study collected data from 395 undergraduate students regarding
lifestyle behaviors and general quality of life across levels of schizotypy.
We found general support for our first hypothesis were Individuals with higher
levels of schizotypy endorsed poorer QOL satisfaction, poorer health behaviors, poorer
nutrition, and poorer overall lifestyle satisfaction than individuals with low or moderate
schizotypy. Additionally, individuals with high levels of schizotypy endorsed more
nicotine use than individuals in the low or medium groups. This finding is consistent with
earlier research that reported higher rates of nicotine use in individuals with
schizophrenia when compared to the general population (Davis et al., 2002; Samele et al.,
2007). While speculative, higher nicotine use may also be a contributing factor to the
lower QOL, poorer health behaviors, and poorer lifestyle satisfaction that we found in our
high schizotypy sample since these outcomes may reflect the consequences of increased
nicotine use. In general, a pattern of poor health behaviors and poor nutrition in our high l
schizotypy group could (ultimately) increase the likelihood of developing chronic and
serious health problems later in life. If individuals in our high schizotypy group develop
schizophrenia, the research literature suggest that the potential consequences of these
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problematic lifestyle behaviors can include an earlier mortality (Brown, 1997), an
increased likelihood of developing obesity, diabetes, and hypertriglyceridemia (Goff et
al., 2005) as well as cardiovascular disease (Beebe, 2008).
For our second hypothesis we anticipated that lifestyle/health behaviors would
moderate the relationship between schizotypy and QOL. However, our results did not
support this hypothesis. Despite this fact, both lifestyle and health behaviors and
schizotypal symptoms were found to independently have an impact on QOL. The
implications of this find might suggests that lifestyle interventions for people with
schizotypy may be useful in improving overall wellbeing, but not sufficient when
conducted alone (i.e., interventions should also target symptom reduction to be optimally
effective). Additionally, it may be possible that the relationship between QOL and health
behaviors and schizotypal symptoms involves factors that we did not specifically
examine (e.g., socioeconomic status). Even if this is the case, our exploratory regression
analyses provide partial evidence for the influence of symptom severity (i.e., SPQ
interpersonal scale), physical health, psychological health, and alcohol use in the
prediction of QOL.
Future research on these specific variables may ultimately contribute to the
development of preventative strategies that are related to improved quality of life among
those with schizophrenia-spectrum conditions. For example, increasing the availability
and utilization of blended psychological services that highlight both lifestyle/health
guidance (exercise courses, nutritional education, etc.) with the mental health care that
addresses interpersonal effectiveness (e.g., strategies to communicate more effectively in
interpersonal interactions) may be more effective than current interventions that tend to
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focus on “positive” symptoms. Although nicotine use was not related to QOL in our
study, targeting nicotine use is still strongly recommended considering the long-term
health consequences related to nicotine use (i.e., heart/lung disease) that will likely
reduce QOL in the future.
Contrary to our predictions, our study found that nutrition and physical activity in
individuals with higher levels of schizotypy were not significantly different from
individuals with lower levels of schizotypy. The average age of our participants was 20.6,
which may have an effect on physical activity levels. Research has shown that younger
individuals report more motivation and intention to engage in sports and older individuals
(Guzman & Kingston, 2012). The average age of our participants may be a confounding
factor since younger individuals may be more likely to engage in athletic activity than
older individuals regardless of levels of schizotypy. Every person in our sample is
enrolled at a four-year, public university that offers fitness resources such as a gym, pool,
exercise classes, and intermural/organized sports making the materials for physical
activity accessible to all students. These programs may also address proper nutrition,
making it more likely that individuals attending college may have more accessibility to
education about proper eating habits and nutrition. Colleges and Universities should
continue to offer health and nutrition related activities to promote a healthier lifestyle
amongst students. It is possible that by offering activities promoting a healthy lifestyle,
all individuals regardless of measured schizotypal symptoms may benefit. Additional
research and information is needed in this area.
There are several limitations of our findings that we acknowledge. First, our
sample consisted of primarily college age individuals at one Northeastern University.
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This may have limited our sample to a very specific portion of the population. The
majority of the individuals in our sample were college age students (18 to 22). Many
individuals in our sample were also of similar socioeconomic statuses and were able to
afford higher education costs. Second, many of our measure involved self-report. This
format is problematic since there may be a number of response biases such as social
desirability or defensiveness that can be introduced. Additionally, as reported in our
study, individuals with higher levels of schizotypy tend to have poorer functioning in
numerous domains. Therefore, individuals with even more serious impairments may be
less likely to enroll in college and, therefore, may not be adequately captured in our
sample. The failure of our study to find evidence for moderation could reflect a Type II
error where elements of our research methodology, or characteristics of our sample,
interfered with our ability to detect moderation. We believe that future research should
strive to better account for these possible considerations and continue to look for complex
moderation effects along with independent factors that contribute to QOL and other
important outcomes in the schizophrenia-spectrum conditions.
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Appendix
Power Analyses
According to power analyses, a minimum sample of 100 would be necessary to identify a
significant relationship schizotypy, QOL, and health behaviors assuming a small effect size
(r=.09), 3 predictors in the model, and using the .05 confidence level to ensure a 90% likelihood
of identifying the relationship. Given the proposed sample size (n=200) and assuming a medium
effect size, the power for detecting a significant relationship would be .95, suggesting that the
proposed study would be sufficiently powered.
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